Nu-Med Plus Announces Increased Patient Safety Of Portable Inhaled Nitric Oxide Delivery

SALT LAKE CITY, UT--(Marketwired - June 30, 2015) -

Highlighted Links

Nu-Med Plus Inc.

Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced that a visual indicator has been created that increases the safe therapeutic delivery of nitric oxide. The indicator is a quick visual check to ensure that by-products of the delivery of nitric oxide are not present in potentially toxic levels.

Nitric oxide is a medically essential gas that is presently used in Neonate Hypoxia therapy and may have future applications for a variety of other diseases and complications that are currently being investigated. Jeff Robins, President and CEO of Nu-Med Plus, Inc. commented, "The indicator adds a level of safety that ensures the patient is receiving as pure a nitric oxide as possible. Physicians and patients will be able to quickly see if the nitric oxide being delivered is free from contaminants."

About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use. For more company information please visit www.nu-medplus.com.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.